The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// CATEGORY GUIDE

Best Peptides for Mood / Motivation in 2026

27 compounds in the Mood / Motivation cluster, ranked by research relevance, mechanism clarity, source availability, and the volume of named-expert discussion.

Ranked Compounds

01

5-HTP

Serotonin precursor used post-MDMA to restore neurotransmitter pools.

2 dosing mentions · 0 vendor recs · 15 PubMed papers

Read research →
02

9-Me-BC

Synthetic β-carboline alkaloid. Not strictly a peptide - a small-molecule nootropic. Studied for dopaminergic neuron support and neurogenesis in dopamine pathways.

10 dosing mentions · 6 vendor recs · 4 PubMed papers

Read research →
03

Ashwagandha

Adaptogen that modestly reduces cortisol (~10 to 20%) and supports stress resilience.

2 dosing mentions · 1 vendor rec · 15 PubMed papers

Read research →
04

Bromantane

Russian-developed adaptogen used for asthenic conditions. Approved as Ladasten in Russia. Not a peptide - adamantane derivative.

18 dosing mentions · 2 vendor recs · 15 PubMed papers

Read research →
05

Dynamine

A caffeine-like analog that acts as an allosteric modulator at adenosine receptor sites, staves off caffeine tolerance, and promotes extra dopamine release.

1 dosing mention · 0 vendor recs · 15 PubMed papers

Read research →
06

Emodin

Plant anthraquinone that inhibits 11β-HSD1 and reduces cortisol production.

1 dosing mention · 1 vendor rec · 15 PubMed papers

Read research →
07

Fish oil (Omega-3)

Anti-inflammatory EPA/DHA source; Nile takes ~10 g/day refrigerated liquid to lower oxidation risk; immediate mood-lifting effect anecdotally.

24 dosing mentions · 6 vendor recs · 15 PubMed papers

Read research →
08

Fluvoxamine

SSRI used by Steve specifically for continuous neurogenesis, not depression.

5 dosing mentions · 0 vendor recs · 14 PubMed papers

Read research →
09

Haloperidol

Antipsychotic that blocks dopamine D1/D2 receptors, used for schizophrenia and bipolar disorder.

0 dosing mentions · 0 vendor recs · 15 PubMed papers

Read research →
10

L-DOPA

Precursor used by the body to synthesize dopamine.

0 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
11

L-Theanine

Amino acid from tea that promotes relaxation and reduces cortisol.

1 dosing mention · 1 vendor rec · 8 PubMed papers

Read research →
12

L-Tyrosine

Amino acid precursor that converts to dopamine and norepinephrine via tyrosine hydroxylase and dopa decarboxylase.

12 dosing mentions · 1 vendor rec · 8 PubMed papers

Read research →
13

Melanotan 2

Synthetic analog of α-MSH (alpha-melanocyte-stimulating hormone). Acts on melanocortin receptors throughout the body.

14 dosing mentions · 1 vendor rec · 15 PubMed papers

Read research →
14

Modafinil

Wakefulness-promoting DAT inhibitor; increases synaptic dopamine.

10 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
15

Oxytocin

Endogenous 9-amino-acid neuropeptide. FDA-approved as Pitocin (synthetic form) for labor induction; off-label use for social/mood enhancement.

12 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
16

P5P

Controls prolactin elevations from weed or 19-nor steroids.

2 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
17

P5P (Pyridoxal-5-Phosphate)

Active form of vitamin B6; cofactor for dopamine synthesis from tyrosine, used to lower prolactin.

4 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
18

PE-22-28

28-amino-acid peptide derived from sortilin / Spadin precursor. Researched as a fast-acting antidepressant via TREK-1 potassium channel blockade.

7 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
19

Phosphatidylserine

Phospholipid that lowers cortisol and supports cognitive function.

2 dosing mentions · 1 vendor rec · 8 PubMed papers

Read research →
20

Quetiapine

Atypical antipsychotic that blocks D1/D2 dopamine receptors; at low dose acts as a powerful hypnotic and may help up-regulate dopamine receptors during addiction recovery.

1 dosing mention · 0 vendor recs · 8 PubMed papers

Read research →
21

Retatrutide

Triple agonist of GLP-1, GIP, and glucagon receptors used for appetite suppression and fat loss, but can blunt dopamine/serotonin reward signaling.

178 dosing mentions · 37 vendor recs · 15 PubMed papers

Read research →
22

Selank

Russian-developed heptapeptide derivative of tuftsin. Used as a prescription anxiolytic in Russia.

7 dosing mentions · 1 vendor rec · 8 PubMed papers

Read research →
23

Selegiline

An MAO-B inhibitor that preserves dopamine by blocking its breakdown, used for Parkinson's and as a longevity / dopaminergic agent.

0 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
24

Semax

Russian-developed heptapeptide analog of ACTH(4-10). Used as a prescription nootropic in Russia for stroke recovery and cognitive enhancement.

14 dosing mentions · 4 vendor recs · 8 PubMed papers

Read research →
25

Teacrine

A methylxanthine caffeine analog that increases dopamine release, providing motivated energy in addition to caffeine-like stimulation.

1 dosing mention · 2 vendor recs · 8 PubMed papers

Read research →
26

Tesofensine

Triple monoamine reuptake inhibitor (NE/DA/5-HT); intense stimulant-like effects and appetite suppression.

3 dosing mentions · 0 vendor recs · 8 PubMed papers

Read research →
27

Vortioxetine

Multimodal antidepressant; reportedly potentiates neurogenesis more than fluvoxamine with cognitive-enhancing benefits.

1 dosing mention · 0 vendor recs · 8 PubMed papers

Read research →

Bottom Comparison Table

CompoundClassDosing mentionsVendorsPapers
5-HTP SUPPLEMENT 2 0 15
9-Me-BC NOOTROPIC 10 6 4
Ashwagandha SUPPLEMENT 2 1 15
Bromantane NOOTROPIC 18 2 15
Dynamine SUPPLEMENT 1 0 15
Emodin SUPPLEMENT 1 1 15
Fish oil (Omega-3) SUPPLEMENT 24 6 15
Fluvoxamine PHARMACEUTICAL 5 0 14
Haloperidol PHARMACEUTICAL 0 0 15
L-DOPA SUPPLEMENT 0 0 8
L-Theanine SUPPLEMENT 1 1 8
L-Tyrosine SUPPLEMENT 12 1 8
Melanotan 2 PEPTIDE 14 1 15
Modafinil PHARMACEUTICAL 10 0 8
Oxytocin PEPTIDE 12 0 8
P5P SUPPLEMENT 2 0 8
P5P (Pyridoxal-5-Phosphate) SUPPLEMENT 4 0 8
PE-22-28 PEPTIDE 7 0 8
Phosphatidylserine SUPPLEMENT 2 1 8
Quetiapine PHARMACEUTICAL 1 0 8
Retatrutide PEPTIDE 178 37 15
Selank PEPTIDE 7 1 8
Selegiline PHARMACEUTICAL 0 0 8
Semax PEPTIDE 14 4 8
Teacrine SUPPLEMENT 1 2 8
Tesofensine PHARMACEUTICAL 3 0 8
Vortioxetine PHARMACEUTICAL 1 0 8

Research Basis

Recent PubMed-indexed papers referencing peptides in this category. Click through for full abstracts and study design.

  1. Vortioxetine: A comprehensive profile. (2026 · Profiles of drug substances,...)
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (2026 · Journal of the American Academy of...)
  3. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. (2026 · Journal of the American Academy of...)
  4. Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. (2026 · Life (Basel, Switzerland))
  5. Insights into Tanning Biology and Tanning Products. (2026 · The Journal of clinical and...)
  6. GIPR:GCGR co-agonism restores normal weight in obese rodents. (2026 · Molecular metabolism)
  7. Metabolic inflammation at the adipose-brain axis. (2026 · Frontiers in physiology)
  8. Triple Hormone Receptor Agonism: The Role of Retatrutide in Addressing Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Comprehensive Review. (2026 · Cardiology in review)

FAQ

How are these ranked?

We rank by mechanism clarity, research relevance, source prevalence, protocol specificity, and how often each appears in expert and community discussions in our source set.

Is this medical advice?

No. This is a research directory and education page. Compounds discussed are framed as research; verify regulatory status and consult a qualified clinician before any decision.

How often is this updated?

Nightly build pulls from the source database. Last build: 2026-07-09.

Methodology

Each compound is profiled with named-expert dosing mentions linked to verbatim source timestamps, vendor recommendations, and PubMed citations. We downgrade compounds when claims exceed the available evidence.